Stifel Nicolaus Has Lowered Expectations for Vor Biopharma (NYSE:VOR) Stock Price
Vor Biopharma (NYSE:VOR – Get Free Report) had its price target lowered by equities researchers at Stifel Nicolaus from $12.00 to $5.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ target price would indicate a potential upside of 474.71% from the stock’s previous close. […]
Vor Biopharma (NYSE:VOR – Get Free Report) had its price target lowered by equities researchers at Stifel Nicolaus from $12.00 to $5.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ target price would indicate a potential upside of 474.71% from the stock’s previous close. […]
